Peptide
USRE37302E · kind E · reissue
16Cited by
1References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 19, 1998 |
| Grant date | Jul 31, 2001 |
| Priority date | — |
| Expiry date | Feb 19, 2018 |
Classification
- Technology area (CPC —)General
Abstract
The invention employs GLP-1(7-37), GLP-1(7-36)amide, and certain related compounds in combination with an oral hypoglycaemic agent for treating diabetes mellitus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.